IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. (Q45968562)

18 December 2017

title

IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. (English)

1 reference

18 December 2017

0 references

Weiwei Feng

1

1 reference

18 December 2017

Weimin Li

2

1 reference

18 December 2017

Wei Liu

3

1 reference

18 December 2017

Fang Wang

4

1 reference

18 December 2017

Yue Li

5

1 reference

18 December 2017

Wei Yan

6

1 reference

18 December 2017

publication date

13 June 2009

1 reference

18 December 2017

Experimental and Molecular Pathology

published in

1 reference

18 December 2017

volume

87

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

212-218

1 reference

18 December 2017

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Matrix metalloproteinase-3 secretion from human pancreatic periacinar myofibroblasts in response to inflammatory mediators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Inhibition of matrix metalloproteinases prevents cardiac hypertrophy induced by beta-adrenergic stimulation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

Fibrotic disease and the T(H)1/T(H)2 paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.06.001

10.1016/J.YEXMP.2009.06.001

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017